Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1960s
|
| gptkbp:ATCCode |
C10AC01
|
| gptkbp:bioavailability |
not absorbed systemically
|
| gptkbp:contraindication |
complete biliary obstruction
|
| gptkbp:eliminatedIn |
fecal
|
| gptkbp:form |
powder for oral suspension
|
| gptkbp:genericName |
gptkb:cholestyramine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Questran
|
| gptkbp:interactsWith |
gptkb:warfarin
gptkb:digoxin gptkb:thiazide_diuretics thyroid hormones fat-soluble vitamins |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:mechanismOfAction |
bile acid sequestrant
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation abdominal discomfort flatulence |
| gptkbp:usedFor |
lowering cholesterol
treating pruritus due to partial biliary obstruction |
| gptkbp:bfsParent |
gptkb:cholestyramine
|
| gptkbp:bfsLayer |
8
|